Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses

Journal of General Virology

Volumn 88, Issue 7, 2007, Pages 2028-2034

  El Mubarak, H Sittana ^a,b   Yüksel, Selma ^a   van Amerongen, Geert ^a   Mulder, Paul G H ^a   Mukhtar, Maowia M ^b   Osterhaus, Albert D M E ^b   de Swart, Rik L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF KHARTOUM   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CLINICAL FEATURE; CONJUNCTIVITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEVER; GENOTYPE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION SENSITIVITY; LUNG ALVEOLUS CELL; LUNG LAVAGE; MACACA; MEASLES; MEASLES VIRUS; NETHERLANDS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RASH; RHESUS MONKEY; SUDAN; VIREMIA; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MACACA FASCICULARIS; MACACA MULATTA; MEASLES; MEASLES VACCINE; MEASLES VIRUS; SPECIES SPECIFICITY;

ANIMALIA; MACACA; MACACA FASCICULARIS; MACACA MULATTA; MEASLES VIRUS; PRIMATES;

EID: 34347364768     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82804-0     Document Type: Article

References (35)

1. Andres, O., Obojes, K., Kim, K. S., Ter Meulen, V. & Schneider-Schaulies, J. (2003). CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol 84, 1189-1197.
2. Auwaerter, P. G., Kaneshima, H., McCune, J. M., Wiegand, G. & Griffin, D. E. (1996). Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol 70, 3734-3740.
3. Auwaerter, P. G., Rota, P. A., Elkins, W. R., Adams, R. J., DeLozier, T., Shi, Y., Bellini, W. J., Murphy, B. R. & Griffin, D. E. (1999). Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis 180, 950-958.
4. Bennett, J. V., Fernandez de Castro, J., Valdespino-Gomez, J. L., De Lourdes Garcia-Garcia, M., Islas-Romero, R., Echaniz-Aviles, G., Jimenez-Corona, A. & Sepulveda-Amor, J. (2002). Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 80, 806-812.
5. De Swart, R. L., Vos, H. W., UytdeHaag, F. G. C. M., Osterhaus, A. D. M. E. & Van Binnendijk, R. S. (1998). Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. J Virol Methods 71, 35-44.
6. De Swart, R. L., Wertheim-van Dillen, P. M. E., Van Binnendijk, R. S., Muller, C. P., Frenkel, J. & Osterhaus, A. D. M. E. (2000). Measles in a Dutch hospital introduced by an immunocompromised infant from Indonesia infected with a new genotype virus. Lancet 355, 201-202.
7. De Swart, R. L., Kuiken, T., Fernandez de Castro, J., Papania, M. J., Bennett, J. V., Valdespino, J. L., Minor, P., Witham, C., Yüksel, S. & other authors (2006). Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. Vaccine 24, 6424-6436.
8. Duke, T. & Mgone, C. S. (2003). Measles: not just another viral exanthem. Lancet 361, 763-773.
9. El Mubarak, H. S., Van de Bildt, M. W. G., Mustafa, O. A., Vos, H. W., Mukhtar, M. M., Groen, J., El Hassan, A. M., Niesters, H. G. M., Ibrahim, S. A. & other authors (2000). Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum. J Clin Microbiol 38, 987-991.
10. El Mubarak, H. S., Ibrshim, S. A., Vos, H. W., Mukhtar, M. M., Mustafa, O. A., Wild, T. F., Osterhaus, A. D. M. E. & De Swart, R. L. (2004). Measles virus protein-specific IgM, IgA, and IgG subclass responses during the acute and convalescent phase of infection. J Med Virol 72, 290-298.
11. Griffin, D. E. (2001). Measles virus. In Fields Virology, 4th edn, pp. 1401-1441. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
12. Hashimoto, K., Ono, N., Tatsuo, H., Minagawa, H., Takeda, M., Takeuchi, K. & Yanagi, Y. (2002). SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 76, 6743-6749.
13. Ibrahim, S. A., Mustafa, O. M., Mukhtar, M. M., Saleh, E. A., El Mubarak, H. S., Abdallah, A., El Hassan, A. M., Osterhaus, A. D. M. E., Groen, J. & other authors (2002). Measles in suburban Khartoum: an epidemiological and clinical study. Trop Med Int Health 7, 442-449.
14. Kobune, F., Takahashi, H., Terao, K., Ohkawa, T., Ami, Y., Suzaki, Y., Nagata, N., Sakata, H., Yamanouchi, K. & Kai, C. (1996). Nonhuman primate models of measles. Lab Anim Sci 46, 315-320.
15. McChesney, M. B., Miller, C. J., Rota, P. A., Zhu, Y., Antipa, L., Lerche, N. W., Ahmed, R. & Bellini, W. J. (1997). Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 233, 74-84.
16. Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. (1993). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025-6032.
17. Niewiosk, S. (2001). Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus). Vaccine 19, 2250-2253.
18. Orenstein, W. A., Hinman, I. R. & Strebel, P. J. (2006). Measles: the need for 2 opportunities for prevention. Clin Infect Dis 42, 320-321.
19. Polack, F. P., Auwaerter, P. G., Lee, S. H., Nousari, H. C., Valsamakis, A., Leiferman, K. M., Diwan, A., Adams, R. J. & Griffin, D. E. (1999). Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 5, 629-634.
20. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493-497.
21. Rimmelzwaan, G. F., Kuiken, T., Van Amerongen, G., Bestebroer, T. M., Fouchier, R. A. M. & Osterhaus, A. D. M. E. (2001). Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 75, 6687-6691.
22. Sellin, C. I., Davoust, N., Guillaume, V., Baas, D., Belin, M. F., Buckland, R., Wild, T. F. & Horvat, B. (2006). High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol 80, 6420-6429.
23. Stittelaar, K. J., Wyatt, L. S., De Swart, R. L., Vos, H. W., Groen, J., Van Amerongen, G., Van Binnendijk, R. S., Rozenblatt, S., Moss, B. & Osterhaus, A. D. M. E. (2000). Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol 74, 4236-4243.
24. Stittelaar, K. J., De Swart, R. L. & Osterhaus, A. D. M. E. (2002). Vaccination against measles: a neverending story. Expert Rev Vaccines 1, 151-159.
25. Stittelaar, K. J., Van Amerongen, G., Kondova, I., Kuiken, T., van Lavieren, R. F., Pistoor, F. H. M., Niesters, H. G. M., van Doornum, G., van der Zeijst, B. A. M. & other authors (2005). Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J Virol 79, 7845-7851.
26. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. (2000). SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897.
27. Van Binnendijk, R. S., Van der Heijden, R. W. J., Van Amerongen, G., UytdeHaag, F. G. C. M. & Osterhaus, A. D. M. E. (1994). Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis 170, 443-448.
28. Van Binnendijk, R. S., Van der Heijden, R. W. J. & Osterhaus, A. D. M. E. (1995). Monkeys in measles research. In Measles Virus, pp. 135-148. Edited by V. Ter Meulen & M. A. Billeter. Berlin: Springer-Verlag.
29. Welstead, G. G., Iorio, C., Draker, R., Bayani, J., Squire, J., Vongpunsawad, S., Cattaneo, R. & Richardson, C. D. (2005). Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc Natl Acad Sci U S A 102, 16415-16420.
30. WHO (1998). Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses. Wkly Epidemiol Rec 73, 265-272.
31. WHO (2004). Measles vaccines. Wkly Epidemiol Rec 79, 130-142.
32. WHO (2005). New genotype of measles virus and update on global distribution of measles genotypes. Wkly Epidemiol Rec 80, 347-351.
33. WHO (2006). Progress in reducing global measles deaths: 1999-2004. Wkly Epidemiol Rec 81, 90-94.
34. Wyde, P. R., Ambrose, M. W., Voss, T. G., Meyer, H. L. & Gilbert, B. E. (1992). Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proc Soc Exp Biol Med 201, 80-87.
35. Yanagi, Y., Takeda, M., Ohno, S. & Seki, F. (2006). Measles virus receptors and tropism. Jpn J Infect Dis 59, 1-5.